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Abstract 
Objectives: The aim of this study was to examine the relative frequency of odontogenic tumours at a tertiary hos-
pital in Ibadan, as well as to study the various histologic types based on WHO 2005 classification and to compare 
results from this study with those of previous studies.
Study design: The records of the Oral Pathology Department of University College Hospital were reviewed. Le-
sions diagnosed as odontogenic tumours were categorized into four groups based on WHO 2005 classification and 
were analyzed for age, sex and site using SPSS for Window (version 18.0; SPSS Inc. Chicago, IL) and frequency 
tables were generated. 
Results: Two hundred and sixty six (41.7%) cases of odontogenic tumours were seen. The mean age of occurrence 
was 32.6 (±15.815) years (range3-82 years) and peak age was in the third decade of life. Eleven (4.1%) malignant 
odontogenic tumours were seen. Ameloblastoma with 65.4% of cases was the most common odontogenic tumour 
followed by fibromyxoma (14.7%), no case of odontoma was seen in this series.
Conclusion: The findings were mostly similar to those of African and Asian series and showed variations from re-
ports from the Americas. The reason for the disparity in African and American series needs further investigations.
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Introduction
Odontogenic tumours (OTs) constitute a wide range and 
diverse kind of lesions derived from tooth forming appa-
ratus and its reminants (1). OTs originate from epithe-
lium or ectomesenchyme or from both, showing varying 
degrees of inductive interaction between these embryo-
nic components of the developing tooth germ (2).
The relative frequency of OTs obtained from studies 
from different parts of the world, have varied widely. 
Some authors have reported that OTs are rare with a re-
lative frequency of 1% (3), while others have reported 
OTs constitute up to 32% (4) of jaw lesions. Furthermo-
re, whilst American (2, 3) studies showed odontomas as 
the most common OT, studies from Africa (4) and Asia 
(1) have shown ameloblastoma to be, overwhelmingly, 
the most common OT. These disparities have being su-
ggested to be due to the differences in terminology and 
classification and also, possibly due to racial and or ge-
netic differences in the occurrence of the various types 
of OTs ( 3).
Although, many reports on OTs are available from lite-
rature, (1, 2, 3, 4) most of these studies were carried out 
before WHO classification of 2005 (5) which included 
Keratocystic odontogenic tumour (KCOT) as an odon-
togenic tumour. The aim of this study was to examine 
the relative frequency of OT seen at the Oral Pathology 
Department of the University College Hospital Ibadan, 
as well as study the various histologic types based on 
WHO 2005 classification and to compare results from 
this study with those of previous studies.
Material and methods
The records of the Oral Pathology Department of Uni-
versity College Hospital Ibadan were reviewed over a 21 
year period (1990-2011). Lesions diagnosed as OTs were 
categorized into four groups based on WHO 2005 clas-
sification (5); Group 1 were malignant tumours, Group 
2 Odontogenic epithelium with mature, fibrous stroma 
without odontogenic ectomesenchyme, Group 3 Odon-
togenic epithelium with odontogenic ectomesenchyme, 
with or without hard tissue formation and Group 4 Me-
senchyme and/or odontogenic ectomesenchyme with or 
without odontogenic epithelium and were analyzed for 
age, sex and site using SPSS for Window (version 18.0; 
SPSS Inc. Chicago, IL) and frequency tables were ge-
nerated.
Results
A total of six hundred and thirty eight jaw lesions were 
diagnosed during the study period, out of these, two hun-
dred and sixty six (41.7%) were OTs. The mean age of 
occurrence was 32.6 (±15.815) years (range 3-82 years) 
and peak age was in the third decade of life. Odontogenic 
tumours occurred more in the mandible with mandible: 
N (%)     
Site Gender Mean age
(years)
Peak agemand max soft male female
MALIGNANT TUMOURS 
Ameloblastic carcinoma      3(1.1) 3 0 0 2 1 32.3±9.5 -
PISCC      7(2.6) 6 1 0 5 2 63.6±18.6 70-79
Ameloblastic fibrosarcoma      1(0.4) 0 1 0 0 1     28 20-29
BENIGN TUMOUR
Odontogenic epithelium with mature, fibrous stroma without odontogenic ectomesenchyme
Ameloblastoma, solid 142(53.4) 132   10 0 87 57 34.4±15.2 20-29
Ameloblastoma, extraosseous        3(1.1) 0    0 3  2 1 37.0 20-29
Ameloblastoma, unicystic type     29(10.9) 26 3 0 10 19 25.6± 8.7 20-29
Squamous odontogenic tumour       1(0.4) 1 0 0 1 0 - -
Calcifying epithelial odontogenic tumour        3(1.1) 1 2 0 1 2 24.0 ±13 -
Adenomatoid odontogenic tumour        6(2.3) 1 5 0 2 4 17.8±4.9 10-19
Keratocystic odontogenic tumour       11(4.1) 9 2 0 6 5 24.1±12.8 10-19, 20-29
Odontogenic epithelium with odontogenic ectomesenchyme, with or without hard tissue formation
Ameloblastic fibroma     11(4.1) 10 1 0 7 4 29.0± 16.6 10-19, 20-29
Ameloblastic fibro-odontoma      1(0.4) 1 0 0 1 0 41.0 40-49
CCOC      4(1.5) 2 1 0 2 2 26.3±15.2 10-19
Mesenchyme and/or odontogenic ectomesenchyme with or without odontogenic epithelium
Odontogenic fibroma      5(1.9) 2 0 3 1 4 38.8± 19.3 40-49
Fibromyxoma   39(14.7) 19 18 1 21 18 31.9 ±15.9 20-29
PISSC- Primary intra-osseous squamous cell carcinoma
CCOC- Calcifying cystic odontogenic tumour
Table 1. Demographic distribution of odontogenic tumours
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OT. Ameloblastoma had an obvious predilection for the 
mandible with 93% of solid ameloblastoma cases oc-
curring in the mandible while 89.7% of cystic amelo-
blastoma occurred in the mandible. The mean age of the 
solid ameloblastoma was 34.4 (±15.2) years while that 
of cystic ameloblastoma was 25.6 (± 8.7) years and both 
had a peak age of occurrence in the third decade of life.
KCOT was the second most common lesion in the Group 
2 category of odontogenic tumours and third most com-
mon odontogenic tumour. A total of 11 cases of KCOT 
were seen, which represented 4.1% of odontogenic tu-
maxilla ratio of approximately 5:1 and 7 cases were seen 
in soft tissue. OTs had a slight male preponderance with 
a male: female of 1.2:1. of the 266 seen, 255 (95.9%) 
were benign, while 11(4.1%) cases of malignant Odon-
togenic tumours were seen.
Table 1 shows demographic distribution of OTs accor-
ding to the WHO 2005 classification. The Group 2 le-
sions were the most common odontogenic tumours with 
195 (73.3%) lesions seen in this category. Ameloblasto-
ma with a total 174 cases representing 65.4% of all OTs 
and 89.2% of Group 2 lesions was the most common 
Author/Year Country /region % of total lesion No of cases % of malignant Top 3 Lesions %
AMERICAS
Masqueda-Taylor et al (2) 
(1997) Mexico A 0.3 349 1.1
Odontoma
AME
Fibromyxoma
34.6
23.7
17.7
Ochsenius et al (3)
(2002)
Chile A 1.29 362 0.6
Odontoma
AME
Fibromyxoma
45.0
20.6
8.9
Buchner et al (7)
(2006)
California/USA A 1.2 1,088 0.4
Odontoma
AME
Fibromyxoma
75.9
11.7
2.2
ASIA
Okada et al (11)
(2007)
Sri-Lanka A - 226 2.7
AME
AOT
Fibromyxoma
69.8
9.3
4.9
Lu et al (1)
(1998)
China A - 759 6.1
AME
Fibromyxoma
AOT
58.6
8.4
8.3
Luo et al (16)
(2009)
China B 8.99 1309 5.1
KCOT
AME
Odontoma
38.7
36.5
6.1
AFRICA
Ladeinde et al (9)
(2005)
Lagos/Nigeria A 9.6 319 3.4
AME
AOT
Fibromyxoma
63.0
7.5
6.5
Arotiba et al (10)
(1997)
Ibadan/ Nigeria A 30 128 2.3
AME
Fibromyxoma
AOT
59.0
16.0
13.0     
Tawfik et al (12)
(2010)
Egypt B - 82 3.7
AME
KCOT
Odontomas       
41.5
19.5
13.4
Present study 
(2012)
Ibadan/ Nigeria B 41.7 266 4.1
AME
Fibromyxoma
AF
KCOT
65.4
14.7
4.1
4.1
AME- Ameloblastoma
AOT- Adenomatoid odontogenic tumour
KCOT-Keratocystic odontogenic tumor
AF ameloblastic fibroma
A-used WHO 1992 Classification
B-used WHO 2005 classification
Table 2. Geographical variations in odontogenic tumours
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mours and 5.6% of the Group 2 lesions. KCOT had a 
marked predilection for the mandible with mandible: 
maxilla ratio of 4.5:1 but had a slight male preponderan-
ce with a male: female ratio of 1.2:1. KCOT had a bimo-
dal peak age of occurrence in the second and third de-
cades of life with a mean age of 24.1 (±12.8) years. Six 
cases of adenomatoid odontogenic tumor (AOT) were 
seen in this series with a predominant maxillary presen-
tation (mandible: maxilla ratio of 1:5) and a female gen-
der predilection (male: female ratio = 1:2). Other lesions 
categorized in the Group 2 lesions (CEOT, SOT) were 
seen occasionally and all together accounted for 1.5% of 
odontogenic tumours and 2.1% of Group 2 lesions.
Group 4 lesions were the second most common category 
of OTs with 44 (16.6%) cases. Fibromyxoma, which had 
39 cases, representing 14.7% of OTs and 88.6% of the 
Group 4 lesions, was the most common lesion in this 
Group and second most common OT. Fibromyxoma had 
no obvious site or gender predilection with a mandible: 
maxilla ratio of 19:18 and male: female ratio of 7:6. 
Group 3 lesions with 16 (6%) of case were the third 
commonest group of lesions in this series. Ameloblastic 
fibroma which was the commonest lesion in this group 
had a mean age of 29.0 (± 16.6) years and had a bimodal 
peak incidence in the second and third decades of life. 
Ameloblastic fibroma had an obvious mandibular pre-
ponderance with 90.9% of cases occurring in the mandi-
ble. A case of ameloblastic fibro-odontoma was seen in 
mandible of a 41 year old male patient.
Group 1 lesions were the least common group of OTs ac-
counting 4.1% of OTs. Primary intra-alveolar squamous 
cell carcinoma (PISCC) was the most common malig-
nant OT seen in this series. Seven cases of PISCC which 
was 2.6% of all OTs and 63.6% of malignant OTs were 
seen. PISCC had a mandibular preponderance (man-
dible: maxilla ratio of 6:1) and a male: female ratio of 
5:2 with a mean age of 63.6±18.6 years and peak age of 
occurrence in 70-79 age group. Ameloblastic carcinoma 
occurred exclusively in the mandible, had a male: fema-
le ratio of 2:1 and a mean age of 32.3 (±9.5) years with 
one case each in the third, fourth and fifth decades. The 
only case of ameloblastic fibro-sarcoma was seen in the 
maxilla of a 28 year old woman.
Discussion
The fact that most studies considering demography of 
OTs were carried out prior to the reclassification of OTs 
(1, 2, 3, 4) by WHO in 2005 and the variations in the ter-
minology and classification by previous authours make 
comparison with other studies quite challenging (Table 
2). Although, many non-African studies have claimed 
that OTs are a relative rare group of lesions, African stu-
dies seem to contradict this notion. Fernandes et al (6) 
in Brazil, Buchner et al (7) in California and Mosqueda-
Taylor et al (2)  in Mexico, reported relative frequen-
cies of OTs to be 1.78%, 1.2% and 2.5% respectively. 
In contrast, Chidzonga et al (8)  in Zimbabwe, Ladeinde 
et al (9)  in Lagos and Adebayo et al (4)  in Kaduna 
reported relative frequencies of 8.6%, 9.6% and 32% 
respectively. The relative frequency of 41% gotten from 
this study is possibly the highest reported in literature 
and may be due to the fact that OTs are relatively more 
prevalent in Africans. Moreover, the relative frequency 
of OTs in this study was gotten from comparison with 
tumours and tumour like lesions of the jaws as compa-
red to other studies whose comparison was based on all 
biopsies. Adebayo et al (4) and Arotiba et al (10) both of 
whom compared OTs with jaw tumours and tumour like 
lesions, also got relatively high frequencies of OTs (32% 
and 30% respectively).
Previous studies from Asia and Africa have reported 
ameloblastoma to be the most common OT (10). Young 
Lu et al (1) and Okada et al (11)  from the Asian conti-
nent showed in their series that ameloblastoma represen-
ted 58.6% and 68.9% of OTs respectively while Ladein-
de et al (9), Adebayo et al (4)  Chidzonga et al (8) and 
Tawfik (12) all from Africa reported that ameloblastoma 
represented 63%,73%,79.1%, and 41.5% of OTs respec-
tively. In this study, ameloblastoma accounted for 65.4% 
of OTs which was in conformity with African and Asia 
studies. 
On the contrary, studies from the Americas have shown 
that odontomas are the commonest OT. Buchner et al (6) 
in California USA, Mosqueda-Taylor et al (2)  in Mexi-
co, Ochsenius et al (3)  in Chile all found odontomas to 
be the most common OT (representing 75.9%, 34.6% 
and 44.7% respectively), however, Fernandes et al (6) 
in Brazil found in their study that ameloblastoma with 
45.2% of their cases was the most common OT. It should 
be observed that no case of odontomas was reported in 
this study which was in contrast with most other studies 
from Americas (2,6,7), Asia (1,11) and Africa (8,9,12). 
This may be due to the fact that many odontomas may 
have been diagnosed and excised by private and secon-
dary dental care providers without subjecting them to 
histological testing. Furthermore, those diagnosed in our 
centre, were mainly incidental radiological findings and 
patients declined appointments for surgical excision and 
histological testing. However, it should be noted that, 
Arotiba et al (10) in a previous study from the same 
centre, also did not find any case of odontomas in their 
series.
There is yet to be a consensus on the possible reason(s) 
for the wide disparity in the occurrence of ameloblasto-
mas and odontomas across the continents; some authors 
have suggested that the Asian and African cases of odon-
tomas may be under reported as orthopanthomogram is 
yet to be routine in clinical examination in some of these 
countries and some cases may not be sent for routine 
histological examination. The suggestion that racial and 
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genetic factors may account for the wide geographical 
variation in occurrence of OTs remains unproven (3).
Ameloblastoma had an obvious mandibular predilection 
in this study with 93% of solid ameloblastoma occurring 
in the mandible while 7% occurred in the maxilla, simi-
larly, 89.7% of cystic ameloblastomas occurred in the 
mandible. This finding was similar to Young Lu et al (1) 
in China, Chidzonga et al (8)  in Zimbabwe and Arotiba 
et al (10)  in Nigeria who reported 92.8%, 95.7% and 
91% of mandibular occurrence for ameloblastoma res-
pectively. The mean age for solid ameloblastoma (34.4 
years) was in agreement with previous studies, (3,8) but 
at variance with some others (4,6,8). Although Reichart 
et al (13) suggested that ameloblastoma tend to occur 
at an early age in developing countries when compared 
with developed ones, this study and some others seems 
(9,10)   to contradict this notion.
The finding that fibromyxoma was the second most 
common OT was corroborated by previous studies from 
Kaduna (4)  and Ibadan but Ladeinde et al (9)  in Lagos 
found AOT to be the second most common OT. Our fin-
ding of a male slight predilection for fibromyxoma was 
in contrast to most studies (2, 3, 4, 14) which reported 
a female preponderance, while a few studies found no 
gender predilection only few previous series have repor-
ted a male predilection (4).
AOT with a maxillary predilection and female prepon-
derance was similar to a previous finding by Arotiba et 
al (15) in Lagos though it was less common (2.3%) in 
this series than in a series from Lagos. The mean age 
of 17.4 years was similar to that from Arotiba et al (15) 
but lower than the 22.6 years gotten from a Chinese se-
ries (1). KCOT which was included in the 2005 WHO 
classification (5) of OT represented 4.1% of OT which 
was lower than the 19.5% reported by Tawfik (12) in 
Egypt and the 38.7% reported by Luo (16) in Chinese 
who found KCOT to be the most common OT is their 
series. Most other studies were done before KCOT was 
included as an OT and did not include KCOT in their 
series. KCOT was seen more in the mandible and had 
a slight male preponderance which was in conformity 
with reports from other series (12, 16).
Malignant OTs accounted for 4.1% of cases which was 
in agreement with most African and Asian series but hig-
her than series from the Americas. Ladeinde et al (9)  in 
Lagos Lu et al (1)  in China got 3.4% and 6.1% respec-
tively while Fernedez et al (6)  in Brazil, Ochsenius et al 
(3)  in Chile and Buchner et al (7)  in California USA, 
reported 0.6%, 0.6% and 0.4% respectively.
The results gotten from this study shows that OTs are 
not rare lesions in Africans and confirms that ameloblas-
toma was the commonest OT in Africans. The findings 
were mostly similar to those of African and Asian series 
and showed variations from reports from the Americas. 
KCOT reported in this study was relative rarer than 
those previously reported and malignant OTs were re-
latively common when compared with American series. 
The reasons for the disparity in African and American 
series and the suggestion that racial and genetic factors 
might account for these differences needs further inves-
tigations.
Conflict of Interest
The authors declare that there are no conflicts of inter-
est.
References
Lu Y, Xuan M, Takata T, Wang C, He Z, Zhou Z, Mock D, Nikai H. 1. 
Odontogenic tumors: A demographic study of 759 cases in Chinese 
population. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 
1998;86:707-14.
Mosqueda-Taylor A, Ledesma-Montes C, Caballero-Sandoval S, 2. 
Portilla-Robertson J, Ruiz-Godoy Rivera LM, Meneses-Garcia A. 
Odontogenic tumors in Mexico: a collaborative retrospective study 
of 349 cases Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 
1997;84:672-5.
Ochsenius G, Ortega A, Godoy L, Peñafiel C, Escobar E. Odon-3. 
togenic tumors in Chile: a study of 362 cases. J Oral Pathol Med. 
2002;31:415-20.
Adebayo ET, Ajike SO, Adekeye EO. A Review of 318 Odon-4. 
togenic Tumors in Kaduna, Nigeria. J Oral Maxillofac Surg. 
2005;63:811-9.
Barnes L, Eveson J, Reichart P, Sidransky D. 2005 World health 5. 
organization classification of tumours. Pathology and genetics of 
head and neck tumours. Lyon: IARC Press.
Fernandes AM, Duarte EC, Pimenta FJ, Souza LN, Santos VR, Mes-6. 
quita RA, de Aguiar MC. Odontogenic  tumors: a study of 340 ca-
ses in a Brazilian population. J Oral Pathol Med. 2005;34:583-7.
Buchner A, Merrell PW, Carpenter WM. Relative frequency of 7. 
central odontogenic tumors: a study of 1,088 cases from Northern 
California and comparison to studies from other parts of the world. 
J Oral Maxillofac Surg. 2006;64:1343-52.
Chidzonga MM, Lopez VM, Alverez AP. Odontogenic tumours: 8. 
analysis of 148 cases in Zimbabwe. Cen Afr J Med. 1996;42:158-
61.
Ladeinde AL, Ajayi OF, Ogunlewe MO, Adeyemo WL, Arotiba 9. 
GT, Bamgbose BO, Akinwande JA. Odontogenic tumors: a review 
of 319 cases in a Nigerian teaching hospital. Oral Surg Oral Med 
Oral Pathol Oral Radiol Endod. 2005;99:191-5.
Arotiba JT, Ogunbiyi JO, Obiechina AE. Odontogenic tumours: a 10. 
15-year review from Ibadan, Nigeria. Br J Oral Maxillofac Surg. 
1997;35:363-7.
Okada H, Yamamoto H, Tilakaratne WM. Odontogenic tumors 11. 
in Sri Lanka: analysis of 226 cases. J Oral Maxillofac Surg. 
2007;65:875-82.
Tawfik MA, Zyada MM. Odontogenic tumors in Dakahlia, Egypt: 12. 
analysis of 82 cases. Oral Surg Oral Med Oral Pathol Oral Radiol 
Endod. 2010;109:e67-73.
Reichart PA, Philipsen HP, Sonner S. Ameloblastoma: biological 13. 
profile of 3,677 cases. Eur J Cancer B Oral Oncol. 1995;31:86-99.
 Odukoya O. Odontogenic tumours, analysis of 289 Nigerian cases. 14. 
J Oral Pathol Med. 1995;24:454-7.
Arotiba GT, Arotiba JT, Olaitan AA, Ajayi OF. The adenomatoid 15. 
odontogenic tumor: an analysis of 57 cases in a black African po-
pulation. J Oral Maxillofac Surg. 1997:55,146-8.
 Luo HY, Li TJ. Odontogenic tumors: a study of 1309 cases in a 16. 
Chinese population. Oral Oncol. 2009;45:706-11. 
